missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18410317

TACE/ADAM17 Antibody (MM0561-8C13), mFluor Violet 450 SE, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-12018MFV450

Product Code. 18410317

  • € 674.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

TACE/ADAM17 Monoclonal antibody specifically detects TACE/ADAM17 in Human samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TACE/ADAM17
Monoclonal
mFluor Violet 450 SE
50mM Sodium Borate
Mouse
Protein G purified
RUO
Primary
Human
Purified
Flow Cytometry
MM0561-8C13
Flow Cytometry
ADAM 17, ADAM metallopeptidase domain 17, ADAM metallopeptidase domain 18, ADAM18, CD156B, CD156b antigen, CSVP, disintegrin and metalloproteinase domain-containing protein 17, EC 3.4.24.86, MGC71942, Snake venom-like protease, TACEcSVP, TNF-alpha convertase, TNF-alpha converting enzyme, TNF-alpha-converting enzyme, tumor necrosis factor, alpha, converting enzyme
Human recombinant TACE/ADAM17
0.1 mL
Alzheimers Research, Apoptosis, Myeloid derived Suppressor Cell, Neurodegeneration, Stem Cell Signaling Pathway
6868
Store at 4C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.